DPM Metals (TSX:DPM) Files Technical Report for Čoka Rakita Gold Project

TORONTO, ON — January 12, 2026 — Leads & Copy —

DPM Metals Inc. (TSX: DPM, ASX: DPM) has announced the filing of a technical report for its Čoka Rakita gold project in Serbia. The report supports the Mineral Resource and Mineral Reserve estimate and feasibility study for Čoka Rakita, as previously disclosed in the company’s news release dated November 26, 2025.

The report was prepared in compliance with Canadian Securities Administrator’s National Instrument 43-101 – Standards of Disclosure for Mineral Projects. The report and the November 26, 2025, news release are available on SEDAR+ (www.sedarplus.ca) and on the company’s website (www.dpmmetals.com).

DPM encourages readers to review the risks, assumptions, and key parameters identified in the report regarding Mineral Resources, Mineral Reserves, and other estimates related to the feasibility study.

DPM Metals Inc. is a Canadian-based international gold mining company with operations and projects in Bulgaria, Bosnia and Herzegovina, Serbia, and Ecuador. The company’s strategic objective is to become a mid-tier precious metals company through sustainable, responsible, and efficient gold production, development of quality assets, and maintaining a strong financial position to support growth in mineral reserves and production via disciplined strategic transactions. This strategy is intended to create a platform for robust growth and deliver above-average returns for shareholders.

DPM trades on the Toronto Stock Exchange (symbol: DPM) and the Australian Securities Exchange as a Foreign Exempt Listing (symbol: DPM).

For further information, contact Jennifer Cameron, Director, Investor Relations, at (416) 219-6177 or jcameron@dpmmetals.com.

Jennifer Cameron
Director, Investor Relations
Tel: (416) 219-6177
jcameron@dpmmetals.com

Source: DPM Metals Inc.

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.